Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Guilherme Rossato de Almeida | Researchclopedia

Back to researchers

Guilherme Rossato de Almeida

AC Camargo Hospital ORCID

31

Works

19

Citations

2

h-index

1

i10-index

Research Topics

Lung Cancer Treatments and Mutations Cancer Immunotherapy and Biomarkers Melanoma and MAPK Pathways

Affiliations

Harvard University2025–2025

AC Camargo Hospital2023–2026

Dana-Farber Cancer Institute2025–2025

Top Works

Safety profile of sacituzumab govitecan in patients with breast cancer: A systematic review and meta-analysis

Maria Inez Dacoregio,Isabella Michelon,et al.

202411 citations

Fibroblast Growth Factor Research

Chronic Lymphocytic Leukemia Research

First-Line MET Tyrosine Kinase Inhibitors versus Immunotherapy ± Chemotherapy for Patients with MET Exon 14 Skipping Mutant Metastatic NSCLC

Federica Pecci,Hui Li,et al.

20254 citations

Factors Associated with Disease Progression after Discontinuation of Immune Checkpoint Inhibitors for Immune-Related Toxicity in Patients with Advanced Non–Small Cell Lung Cancer

Federica Pecci,Rohit Thummalapalli,et al.

20252 citations

Efficacy and Safety of Tarlatamab in a Patient With Advanced Delta-Like Ligand 3-Positive Large Cell Neuroendocrine Lung Carcinoma and Untreated Brain Metastases: A Case Report

Eleonora Gariazzo,Sanna Laaksonen,et al.

20252 citations

Supplementary Figure 5 from First-Line MET Tyrosine Kinase Inhibitors versus Immunotherapy ± Chemotherapy for Patients with MET Exon 14 Skipping Mutant Metastatic NSCLC

Federica Pecci,Hui Li,et al.

20250 citations

Supplementary Figure 5 from Factors Associated with Disease Progression after Discontinuation of Immune Checkpoint Inhibitors for Immune-Related Toxicity in Patients with Advanced Non–Small Cell Lung Cancer

Federica Pecci,Rohit Thummalapalli,et al.

20250 citations

Supplementary Figure 3 from First-Line MET Tyrosine Kinase Inhibitors versus Immunotherapy ± Chemotherapy for Patients with MET Exon 14 Skipping Mutant Metastatic NSCLC

Federica Pecci,Hui Li,et al.

20250 citations

Supplementary Figure 6 from Factors Associated with Disease Progression after Discontinuation of Immune Checkpoint Inhibitors for Immune-Related Toxicity in Patients with Advanced Non–Small Cell Lung Cancer

Federica Pecci,Rohit Thummalapalli,et al.

20250 citations

Abstract P3-11-30: Low Ki67 is associated with a lower pathological complete response rate after neoadjuvant therapy in HER2-positive breast cancer patients

B. S. S. De Silva,Mario Machado Lopes,et al.

20250 citations